MUMBAI: Sun Pharmaceutical Industries Ltd is scouting for a partner in China to help it win a larger piece of the world’s second-largest drug market, where the government is on a mission to drive down healthcare costs.
With recovery underway in its US business, Sun Pharma’s billionaire founder Dilip Shanghvi is honing in on China and believes market watchers are underestimating the potential there for India’s largest drugmaker.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!